Pharmaceutical products are one of the most vulnerable goods for counterfeiting practices worldwide. Counterfeiting practices involve substitution of original medicine with substandard drug containing toxic substance or no active ingredient at all. Anti-counterfeiting technologies are applied to nullify adverse impact on health of patients, which may lead to death of patient in extreme cases. Pharmaceutical industry has one of the highly complex supply chain management network, which makes it relatively difficult to track products from end to end platform, thereby increasing demand for counterfeiting practice. Unlike other products in which counterfeiting practices could be identified with visual appearance of the product by the end user, pharmaceutical products could not be identified for their spurious content by the end user or other stake holder. Moreover, various patented products of high price are counterfeited with spurious content to gain high profit. Anti-counterfeiting technologies consist of different types such as track and trace technologies, cohort technologies, overt technologies, and forensic technologies. Drugs that are commonly counterfeited include birth control drugs, anti-malarial, and other lifesaving drugs. Although there is a rapid change in technology landscape such as availability of smartphones, burden of anti-counterfeiting practices are increasingly shared by the end users.

Market Dynamics

Pharmaceutical anti-counterfeiting technologies market is majorly driven by the increasing incidence of counterfeiting medicines affecting patient health and overall human capital. According to the International Trade Administration Top Market Reports on Pharmaceuticals published in 2016, the global market for counterfeit drugs valued at number of US$ 75 - 200 billion, which is a serious threat to the health of people worldwide. In 2017, the Pharmaceutical Security Institute (PSI) report stated a rise in drug diversion incidents around the world, which includes diversion of medicines supplied for compassionate use. Moreover, serious health incidence or eventual death due to the consumption of counterfeit drugs are major factors increasing the demand for anti-counterfeiting technologies, which would propel growth of pharmaceutical anti-counterfeiting technologies market. According to the estimate by the International Criminal Police Organization, (Interpol) counterfeit drugs causes more than 1 million death every year. Increasing intervention by government and other health authorities such as WHO, OECD, and Interpol to tackle the problem of counterfeit drugs is also expected to drive growth of pharmaceutical anti-counterfeiting technologies market size over the forecast period. For instance, the European Union launched EU Falsified Medicines Directive to control the volume of counterfeit drugs. Launch of new and innovative platforms in anti-counterfeiting technologies is another major factor driving growth of the market, as it results in more resilient technology at lower cost and provides high protection to the medicines. For instance, in 2017, Clariant introduced Plastiward system, which uses covert taggants developed by SICPA SA to supply an integrated plastic-based anti-counterfeiting technology that can be used in pharmaceutical packaging. They applied DNA technologies to develop signature molecular tracking system, which can be used in the tracking and tracing of legal cannabis for medical use. Other emerging technologies such as DNA based technology and intelligent packaging (printed electronics, micro sensors, Iot) would be commercialized in the near future.

Regional Insights

On the basis of region, the global pharmaceutical anti-counterfeiting technologies market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America holds a dominant position in the market due to rising number of counterfeit drugs and stringent regulations related to counterfeit drugs. It is observed that the FDA seized nearly US$ 73 million in counterfeit drugs in the year 2014. Moreover, the opioid addiction has led to increased levels of counterfeit opioids such as fentanyl. The U.S. enacted legislations such as the U.S. Drug Supply Chain Security Act (DSCSA) in 2017 that mandates pharmaceutical manufacturers to identify pharmaceuticals at the unit package level, in order to trace the product within the supply chain. This is done to prevent pharmaceutical product counterfeiting. Moreover, Asia Pacific is expected to witness significant growth in the market over the forecast period due to the maximum number of counterfeit drugs available in this region. According to The World Health Organization (WHO) fact sheet 2017, around 1 in 10 medical products used in low- and middle-income economies are either substandard or falsified and up to 30 per cent of branded drugs sold in these economies are counterfeit. According to the Pharmaceutical Security Institute in 2017, maximum arrest (51%) cases in association with the counterfeiting of pharmaceuticals are observed in Asia Pacific.

Major players are adopting strategic collaborations and launching new products, in order to retain their position in the market. Daily Wellness Company chose TruTag’s platform for its nutraceuticals and health products, in which products would be tagged to allow detection and authentication throughout the supply chain. The company collaborated with Sumitomo Corporation in the U.S. to invest and develop its technology for pharmaceutical industry. In May 2017, Alien Technology launched the ALR-F800-X with Emissary, which would simplify RFID reader infrastructure, installation, operations, and maintenance.

Market Taxonomy

On the basis of product type, the global pharmaceutical anti-counterfeiting technologies market is segmented into:

RFID

Bar coding

QR Coding

Holography

Security Ink

Taggants

Others

On the basis of technology, the global pharmaceutical anti-counterfeiting technologies market is segmented into:

Overt Technologies

Cohort Technologies

Forensic Technologies

Track and Trace Technologies

Others

On the basis of geography, the global pharmaceutical anti-counterfeiting technologies market is segmented into:

Coherent Market Insights followsa comprehensive research methodology focused on providing the most precise market analysis. The company leverages a data triangulation model which helps company to gauge the market dynamics and provide accurate estimates. Key components of the research methodologies followed for all our market reports include:

Primary Research (Trade Surveys and Experts Interviews)

Desk Research

Proprietor Data Analytics Model

In addition to this, Coherent Market Insights has access to a wide range of the regional and global reputed paid data bases, which helps the company to figure out the regional and global market trends and dynamics. The company analyses the industry from the 360 Degree Perspective i.e. from the Supply Side and Demand Side which enables us to provide granular details of the entire ecosystem for each study. Finally, a Top-Down approach and Bottom-Up approach is followed to arrive at ultimate research findings.

Coherent Market Insights desk research is based on a principle set of research techniques:

National level desk research: It Includes research analysis of regional players, regional regulatory bodies, regional trade associations, and regional organization.

Coherent Market Insights has a large amount of in-house repository of industry database. This is leveraged as a burner for initiating a new research study. Key secondary sources include:

Governmental bodies, National and international social welfare institutions, and organizations creating economic policies among others.

Trade association, National and international media and trade press.

Company Annual reports, SEC filings, Corporate Presentations, press release, news, and specification sheet of manufacturers, system integrators, brick and mortar - distributors and retailers, and third party online commerce players.

Scientific journals, and other technical magazines and whitepapers.

Preliminary Data Mining

The raw data is obtained through the secondary findings, in house repositories, and trade surveys. It is then filtered to ensure that the relevant information including industry dynamics, trends, and outlook is retained for further research process.

Data Standardization:

Holistic approach is used to ensure that the granular and uncommon parameters are taken into consideration to ensure accurate results. The information from the paid databases are further combined to the raw data in order to standardize it.

Coherent Statistical model

We arrive at our final research findings through simulation models. Coherent Data Analytics Model is a statistical tool that helps company to forecast market estimates. Few of the parameters considered as a part of the statistical model include:

Micro-economic indicators

Macro-economic indicators

Environmental indicators

Socio-political indicators

Technology indicators

Data Processing

Once the findings are derived from the statistical model, large volume of data is process to confirm accurate research results. Data analytics and processing tools are adopted to process large chunk of collected informative data. In case, a client customizes the study during the process, the research finding till then are benchmarked, and the process for new research requirement is initiated again.

Data Validation

This is the most crucial stage of the research process. Primary Interviews are conducted to validate the data and analysis. This helps in achieving the following purposes:

It provides first-hand information on the market dynamics, outlook, and growth parameters.

Industry experts validates the estimates which helps the company to cement the on-going research study.